Assertio Therapeutics Announces FDA Notification of Acceptance for Filing of 505(b)(2) NDA for Long-acting Cosyntropin
February 19, 2019 08:30 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that it has received notification of acceptance for filing from the U.S. Food and Drug...
Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
February 19, 2019 08:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Heather L. Mason has been appointed to the Company’s Board of Directors. Ms....
Assertio Therapeutics Announces Amendment of its Senior Secured Credit Facility
January 09, 2019 07:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has amended its Senior Secured Credit Facility, replacing the previous fixed...
Assertio Therapeutics Announces Submission of NDA for FDA Approval of Cosyntropin Depot
December 20, 2018 09:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it has submitted to the U.S. Food and Drug Administration a 505(b)(2) New Drug...
Assertio Therapeutics Announces Third-Quarter 2018 Financial Results
November 08, 2018 16:06 ET
|
Assertio Therapeutics, Inc.
-- Confirms Full-Year Net Sales Guidance Range for the Neurology Franchise ---- Raises Full-Year Earnings Guidance and Confirms Adjusted EBITDA Guidance ---- Amends and Strengthens Commercial...
Assertio Therapeutics Announces the Appointment of Daniel A. Peisert as Senior Vice President and Chief Financial Officer; Current CFO Phil B. Donenberg to Retire November 30, 2018
October 29, 2018 16:05 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that Phillip B. Donenberg, Senior Vice President and Chief Financial Officer, will...
Assertio Therapeutics to Participate in Upcoming Investor Conferences
October 17, 2018 08:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that...
Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018
October 08, 2018 07:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release third-quarter 2018 financial results on Thursday, November 8,...
Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare Conference
September 05, 2018 08:00 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, today announced that...
Assertio Therapeutics and Purdue Pharma Settle Patent Infringement Lawsuit
August 28, 2018 16:36 ET
|
Assertio Therapeutics, Inc.
LAKE FOREST, Ill., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that the Company has entered into a settlement agreement with Purdue Pharma L.P. with...